Literature DB >> 7055744

Effects of neostigmine and pyridostigmine on serum cholinesterase activity.

R K Mirakhur, T D Lavery, L P Briggs, R S Clarke.   

Abstract

Serum cholinesterase activities were measured from 270 minutes in patients following administration of neostigmine or pyridostigmine for the reversal of pancuronium block in groups of seven patients each. The enzyme activities were significantly depressed by neostigmine for four hours and by pyridostigmine throughout the whole period of study. Whereas the immediate effects of neostigmine were more intense, the effects of pyridostigmine beyond the first 30 minutes were more profound. The clinical relevance of these findings is discussed.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7055744     DOI： 10.1007/bf03007949

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN： 0008-2856


  13 in total

Review 1.  THE CHOLINESTERASES AND THEIR SIGNIFICANCE TO THE ANAESTHETIST USING MUSCLE RELAXANTS.

Authors:  M D VICKERS
Journal:  Br J Anaesth       Date:  1963-09       Impact factor: 9.166

2.  Prolonged apnoea after suxamethonium in man.

Authors:  D E ARGENT; O P DINNICK; F HOBBIGER
Journal:  Br J Anaesth       Date:  1955-01       Impact factor: 9.166

3.  Prolonged response to succinylcholine following pancuronium reversal with pyridostigmine.

Authors:  E W Bentz; R K Stoelting
Journal:  Anesthesiology       Date:  1976-03       Impact factor: 7.892

4.  Serum cholinesterase activity following pancuronium and antagonism with neostigmine or pyridostigmine.

Authors:  R K Stoelting
Journal:  Anesthesiology       Date:  1976-12       Impact factor: 7.892

Review 5.  Antagonism of neuromuscular blockade.

Authors:  R D Miller
Journal:  Anesthesiology       Date:  1976-04       Impact factor: 7.892

6.  Effects of neostigmine and pyridostigmine on duration of succinylcholine action and pseudocholinesterase activity.

Authors:  K Y Sunew; R G Hicks
Journal:  Anesthesiology       Date:  1978-09       Impact factor: 7.892

7.  Clearance of neostigmine from the circulation during the antagonism of neuromuscular block.

Authors:  N E Williams; T N Calvey; K Chan
Journal:  Br J Anaesth       Date:  1978-10       Impact factor: 9.166

8.  Serum cholinesterase in anaesthesia with reference to neostigmine, fentanyl, and dihydrobenzpiridol.

Authors:  J W McIntyre; D J Campbell
Journal:  Can Anaesth Soc J       Date:  1966-11

9.  The inhibition of cholinesterases by pancuronium.

Authors:  J Stovner; N Oftedal; J Holmboe
Journal:  Br J Anaesth       Date:  1975-09       Impact factor: 9.166

10.  Plasma clearance of neostigmine and pyridostigmine in the dog.

Authors:  P R Baker; T N Calvey; K Chan; C M Macnee; K Taylor
Journal:  Br J Pharmacol       Date:  1978-07       Impact factor: 8.739
View more
  8 in total

Review 1.  Neuromuscular transmission and its pharmacological blockade. Part 3: Continuous infusion of relaxants and reversal and monitoring of relaxation.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

2.  Technical report: exploring the basis of congenital myasthenic syndromes in an undergraduate course, using the model organism, Caenorhabditis elegans.

Authors:  Bonnie Kaas; Avinash R Vaidya; Amanda Leatherman; Stephanie Schleidt; Rebecca Eustance Kohn
Journal:  Invert Neurosci       Date:  2010-04-30

3.  The reversal of profound mivacurium-induced neuromuscular blockade.

Authors:  Y J Kao; N D Le
Journal:  Can J Anaesth       Date:  1996-11       Impact factor: 5.063

4.  Neostigmine but not edrophonium prolongs the action of mivacurium.

Authors:  M J Symington; R K Mirakhur; N Kumar
Journal:  Can J Anaesth       Date:  1996-12       Impact factor: 5.063

5.  Edrophonium and plasma cholinesterase activity.

Authors:  R K Mirakhur
Journal:  Can Anaesth Soc J       Date:  1986-09

6.  Determination of erythrocyte-bound acetylcholinesterase activity for monitoring pyridostigmine therapy in myasthenia gravis.

Authors:  T Henze; M Nenner; H C Michaelis
Journal:  J Neurol       Date:  1991-07       Impact factor: 4.849

Review 7.  Adverse reactions and interactions of the neuromuscular blocking drugs.

Authors:  D Ostergaard; J Engbaek; J Viby-Mogensen
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Sep-Oct

8.  Current use of neuromuscular blocking agents and antagonists in Korea: a 2018 survey.

Authors:  Jin Sun Kim; Jung Woo Han; Jae Ho Lee; Jae Moon Choi; Ha Jung Kim; Tae-Yun Sung; Yong Beom Kim; Yong Seop Shin; Hong Seuk Yang
Journal:  Anesth Pain Med (Seoul)       Date:  2019-10-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.